Primary hyperoxaluria

Contributions to Nephrology

Volumn 122, Issue , 1997, Pages 143-159

  Watts, Richard W E ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b WELLINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE GLYOXYLATE AMINOTRANSFERASE; ALANINE-GLYOXYLATE TRANSAMINASE; AMINOTRANSFERASE; CALCIUM OXALATE; GLYOXYLIC ACID; GLYOXYLIC ACID DERIVATIVE; OXALIC ACID; OXALIC ACID DERIVATIVE;

ENZYMOLOGY; GENETICS; HUMAN; LIVER; METABOLISM; MICROBODY; MUTATION; OXALOSIS 1; REVIEW;

CALCIUM OXALATE; GLYOXYLATES; HUMANS; HYPEROXALURIA, PRIMARY; LIVER; MICROBODIES; MUTATION; OXALATES; OXALIC ACID; TRANSAMINASES;

EID: 0031306867     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000059893     Document Type: Article

References (36)

1. Ratner S, Nocito V, Green DE: Glycine oxidase. J Biol Chem 1944; 152:113-119.
2. Scowen EF, Stansfeld A, Watts RWE: Oxalosis and primary hyperoxaluria. J Pathol Bact 1959;77:159 295
3. Marangello M, Petrarulo M, Vitale C, Daniela PG, Sammartano S, Cosseddu D, Linari F: Serum calcium oxalate saturation in patients on maintenance haemodialysis for primary hyperoxaluria and oxalosis unrelated diseases. Clin Sci 1991;81:483-490.
4. Cooper PJ, Danpure CJ, Wise PJ, Guttridge KM: Immunocytochemical localisation of human hepatic alanine: glyoxylate aminotransferase in control subjects and patients with primary hyperoxaluria type I. J Histochem Cytochem 1988;36:1285-1294.
5. Purdue PE, Takada Y, Danpure CJ: Identification of mutations associated with peroxisome-to-mitochondrion mistargettting of alanine/gloyoxylate aminotransferase in primary hyperoxaluria type I. J Cell Biol 1990;111:2341-2351.
6. Danpure CJ, Guttridge KM, Fryer P, Jennings PR, Allsop J, Purdue PE: Subcellular distribution of hepatic alanine;glyoxylate aminotransferase in various mammalian species. J Cell Sci 1990;97: 669-678.
7. Danpure CJ, Fryer P, Jennings PR, Allsop J, Griffiths S, Cunningham A: Evolution of alanine: glyoxylate aminotransferase 1 peroxisomal and mitochondrial targetting. A survey of its distribution in the livers of various representatives of the classes Mammalia, Aves and Amphibia. Eur J. Cell Biol 1994;64:295-313.
8. Gibbs DA, Watts RWE: The action of in pyridoxine in primary hyperoxaluria. Clin Sci 1970;38: 277-286.
9. Watts RWE, Veall N, Purkiss P, Mansell MA, Haywood EF: The effect of pyridoxine on oxalate dynamics in three cases of primary hyperoxaluria (wih glycollic aciduria). Clin Sci 1985:69:87-90.
10. Danpure CJ: Primary hyperoxaluria type I and peroxisomc-to-mitochondrion mis-targetting of alanine:glyoxylate aminotransferase. Biochimie 1993;75:309-315.
11. Danpure CJ, Purdue PE, Fryer P, Griffiths S, Allsop J, Lumb MJ, Guttridge KM, Jennings PR, Scheinman JI, Mauer SM, Davidson NO: Enzymological and mutational analysis of a complex primary hyperoxaluria phenotype involving alanine:glyoxylate aminotransferase peroxisome-to-mitochondrial mis-targetting and intra-peroxisomal aggregation. Am J Hum Genet 1993:53:417-432.
12. Iancu TC, Danpure CJ: Primary hyperoxaluria type I: Ultrastructural observations in liver biopsies. J Inherit Metab Dis 1987:10:330-338.
13. Danpure CJ, Birdsey GM, Rumsby G, Lumb MJ, Purdue PE, Allsop J: Molecular characterisation and clinical use of a polymorphic tandem repeat in an intron of the human alanine:glyoxylate aminotransferase gene. Hum Genet 1994;94:55-64.
14. Danpure CJ: Advances in enzymology and molecular genetics of primary hyperoxaluria type 1. Prospects for gene therapy. Nephrol Dial Transplant 1995;10(suppl 8):24-29.
15. von Heijne C: Mitochondrial targetting sequences may form amphiphillic helices. EMBO J 1986; 5:1335-1342.
16. Purdue PE, Lumb MJ, Allsop J, Danpure CJ: An intrinsic duplication in the alanine:glyoxylate aminotransferase gene facilitates identification of mutations in compound heterozygote patients with primary hyperoxaluria type I. Hum Genet 1991:87:394-396.
17. Kasidas GP, Rose A: Measurement of plasma oxalate in healthy subjects and in patients with chronic renal failure using immobilised oxalate oxidase. Clin Chim Acta 1986:154:49-58.
18. Watts RWE, Mansell MA: Primary hyperoxaluria; in Rose GA (ed): Oxalate Metabolism in Relation to Urinary Stone. Berlin, Springer, 1988.
19. Allen A, Clutterbuck E, Maidment G, Thompson E, Watts RWE, Pusey C: Enteric hyperoxaluria and renal failure associated with lymphangiectasia. Nephrol Dial Transplant 1997;12:802-806.
20. Barratt TM, van't Hoff WG: Are there guidelines for a strategy according to glomerular filtration rate, plasma oxalate determination and the risk of oxalate accumulation? Nephrol Dial Transplant 1995;10(suppl 8):22-23.
21. Danpure CJ, Jennings PR: Further studies on the activity and subcellular distribution of alanine: glyoxylate aminotransferase in the livers of patients with primary hyperoxaluria type I. Clin Sci 1988;75:315-322.
22. Allsop J, Jennings PR, Danpure CJ: A new micro-assay for human liver alanine:glyoxylate aminotransferase. Clin Chim Acta 1987;170:187-193.
23. Wise PJ, Danpure CJ, Jennings PR: Immunological heterogeneity of hepatic alanine:glyoxylate aminotransferase in primary hyperoxaluria type I. FEBS Lett 1987;222:17-20.
24. Watts RWE: Treatment of primary hyperoxaluria type I. J Nephrol 1994;7:208-214.
25. Leumann E, Hoppe B, Neuhaus T, Blau N: Efficacy of oral citrate administration in primary hyperoxaluria. Nephrol Dial Transplant 1995;10(suppl 8):14-16.
26. Danpure CJ, Jennings PR, Watts RWE: Enzymological diagnosis of primary hyperoxaluria type I by measurement of hepatic alanine:glyoxylate aminotransferase. Lancet 1987; i:289 291.
27. Wanders RJA, van Roermund CWT, Jurriaans S, Schutgens RBH, Tager JM, van den Bosch H, Wolff D, Przyembel H, Berger R, Schaaphok FG, Reetsma W, van Luyk WHJ: Diversity in residual alanine:glyoxylate aminotransferase activity in hyperoxaluria type I: Correlation with pyridoxine responsiveness. J Inherit Metab Dis 1988;11(suppl 21):208 211.
28. Watts RWE, Calne RY, Williams R, Mansell MA, Veall N, Purkiss P, Rolles K: Primary hyperoxaluria (Type I): Attempted treatment by combined hepatic and renal transplantation. Q J Med 1995;NS57: 697-703.
29. Watts RWE, Calne RY, Rolles K, Danpure CJ, Morgan SH, Mansell MA, Williams R, Purkiss P: Successful treatment of primary hyperoxaluria type I by combined hepatic and renal transplantation. Lancet 1987;ii:474-475.
30. Calne RY, Sells RA, Perma JR, Davis DR, Millard PR, Herbertson BM, Bruno RM, Davies DAL: Induction of immunological tolerance by porcine liver allograft. Nature 1969;223:472-476.
31. Clane RY, White HJO, Burns RM, Herbertson BM, Millard PR, Pena J, Salaman JR, Samuel JR, Davis DR: Immunosuppressive effects of the orthotopically transplanted porcine liver. Transplant Proc 1969;1:321 324.
32. Calne RY, Davies H: Organ graft tolerance: The liver effect. Lancet 1994;343:67-68.
33. Allan A, Thompson E, Watts RWE, Williams G, Pusey C: Selective renal transplantation in primary hyperoxaluria. Am J Kidney Dis 1996;27:891-895.
34. Cochat P, Faure JL, Diury P, Danpure CJ, Descos B, Wright C, Takurian P, Floret D: Liver transplantation in primary hyperoxaluria type I. Lancet 1989;i:1142-1143.
35. Schürman G, Schärer K, Wingen AM, Otto G, Herfarth C: Early liver transplantation for primary hyperoxaluria type I. Nephrol Dial Transplant 1990;5:825-827.
36. Watts RWE, Danpure CJ, De Pauw L, Toussaint C, and the European Study Group on Transplantation in Hyperoxaluria Type I: The European Experience. Nephrol Dial Transplant 1991;6:502-511.